Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · EFFECT

SiNtx Technologies, Inc.

SINTNASDAQEQUITYCurrent

SEC Filing

Filed Aug 18, 2026Accepted Aug 19, 2026, 12:15 AM EDTCIK 1269026Accession 9999999995-26-002702
Share

Company context

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities, and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.

Current securities

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G filingAug 13, 2026
  2. Regulation FD Disclosure · Other EventsAug 13, 2026
  3. S-3 filingAug 13, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 11, 2026
  5. 10-Q filingAug 11, 2026

As-filed source

Primary evidence